Antoine Papiernik

Antoine Papiernik is a Managing Partner at the life sciences VC firm Sofinnova Partners. He has been an initial investor and active board member in Actelion, ProQR, NovusPharma, Movetis, Mainstay, Pixium Vision and Stentys, among others.

China opinion piece

30/09/2019 3 mins

Can European Biotech Companies Afford Not to Work with China?

Biotech investment - opinion 2

16/07/2019 4 mins

The Business of Biotech: What to Do When the S*#t Hits the Fan

Going public - opinion

05/06/2019 6 mins

Is Going Public in Europe the Kiss of Death?